The Patetent owner is the PIRBRIGHT Institute owned by Gates.
The Pirbright Institute
Date: November 2013
Purpose: to improve our understanding of, and effective use of, current control tools and measures (including vaccines) against peste des petits ruminants and foot and mouth disease, two serious diseases affecting livestock that are widespread in developing countries
Amount: $189,232
Term: 49
Topic: Agricultural Development
Program: Global Growth and Opportunity
Grantee Location: Woking, Surrey
Grantee Website: The Pirbright Institute | Preventing and controlling viral diseases
OPP1098099
Coronavirus
Patent number: 10130701
Abstract: The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.
Type: Grant
Filed: July 23, 2015
Date of Patent: November 20, 2018
Assignee: THE PIRBRIGHT INSTITUTE
Inventors: Erica Bickerton, Sarah Keep, Paul Britto